HighTower Advisors’s GMO US Value ETF GMOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Buy
130,564
+4,350
+3% +$129K ﹤0.01% 1392
2026
Q1
$3.55M Buy
126,214
+3,104
+3% +$88.5K ﹤0.01% 1382
2025
Q4
$3.38M Buy
123,110
+2,182
+2% +$58.4K ﹤0.01% 1376
2025
Q3
$3.2M Buy
120,928
+3,371
+3% +$87.4K ﹤0.01% 1371
2025
Q2
$2.97M Buy
117,557
+12,139
+12% +$290K ﹤0.01% 1351
2025
Q1
$2.59M Buy
+105,418
New +$2.64M ﹤0.01% 1384

Other funds holding GMOV

HighTower Advisors's GMOV Position: Q2 2026 in Review

HighTower Advisors increased its GMO US Value ETF (GMOV) stake by 3.4% in Q2 2026, buying an estimated $129K and bringing the position to 130,564 shares worth $3.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

HighTower Advisors first reported a position in GMOV in Q1 2025 and has held it in 6 quarters since. 19 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.

  • HighTower Advisors held 130,564 shares of GMO US Value ETF worth $3.89M as of Q2 2026.
  • HighTower Advisors bought 4,350 GMO US Value ETF shares in Q2 2026, an estimated $129K.
  • GMO US Value ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1392 holding.
  • HighTower Advisors first reported a position in GMO US Value ETF in Q1 2025 and has held it in 6 quarters since.
  • 19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.